Precision BioSciences Inc
General ticker "DTIL" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $43.2M
Precision BioSciences Inc does not follow the US Stock Market performance with the rate: -34.9%.
Estimated limits based on current volatility of 5.1%: low 4.34$, high 4.81$
Factors to consider:
- Current price 45.3% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [14.19$, 41.65$]
- 2023-12-31 to 2024-12-30 estimated range: [8.23$, 24.65$]
Financial Metrics affecting the DTIL estimates:
- Negative: Non-GAAP EPS, $ of -41.44 <= 0.10
- Negative: Operating profit margin, % of -80 <= 1.03
- Negative: Operating cash flow per share per price, % of -30.29 <= 2.35
- Negative: negative Net income
- Negative: Industry operating profit margin (median), % of -98.17 <= 2.14
- Negative: Industry operating cash flow per share per price (median), % of -21.66 <= 3.85
Short-term DTIL quotes
Long-term DTIL plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $24.29MM | $115.53MM | $25.10MM |
| Operating Expenses | $134.11MM | $154.93MM | $125.46MM |
| Operating Income | $-109.83MM | $-39.40MM | $-100.37MM |
| Non-Operating Income | $1.64MM | $17.73MM | $-11.27MM |
| Interest Expense | $0.00MM | $0.13MM | $1.11MM |
| R&D Expense | $98.06MM | $115.24MM | $83.94MM |
| Income(Loss) | $-108.18MM | $-21.67MM | $-111.64MM |
| Taxes | $0.00MM | $0.00MM | $11.27MM |
| Profit(Loss) | $-108.18MM | $-21.67MM | $-122.91MM |
| Stockholders Equity | $44.42MM | $91.17MM | $60.43MM |
| Inventory | $5.76MM | $17.43MM | $7.55MM |
| Assets | $150.16MM | $211.50MM | $238.17MM |
| Operating Cash Flow | $-87.39MM | $-10.85MM | $-45.75MM |
| Capital expenditure | $5.03MM | $5.80MM | $3.32MM |
| Investing Cash Flow | $-5.03MM | $-5.80MM | $-3.32MM |
| Financing Cash Flow | $1.33MM | $70.52MM | $94.98MM |
| Earnings Per Share* | $-62.85 | $-15.80 | $-41.95 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.